Abstract
While there has been substantial experimental evidence in support of the telomere-telomerase hypothesis of aging and cancer, it has been suggested that the theory has been oversimplified to the exclusion of alternative mechanisms in the progression of cancer. This review strives to present an overview of some of the areas that have not been well explained and to indicate where multiple interpretations of the data are possible.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harley, C.B., Futcher, A.B., and Greider, C.W. 1990. Telomeres shorten during aging. Nature 345: 458–460.
Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11: 1921–1929.
Shay, J.W., Werbin, H., and Wright, W.E. 1995. You haven't heard the end of it: telomere loss may link human aging with cancer. Canad. J. Aging 14: 511–524.
Counter, C.M., Gupta, J., Harley, C.B., Leber, B., and Bacchetti, S. 1995. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315–2320.
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M.A., and Shay, J.W. 1995. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1: 249–255.
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M.A., Shay, J.W., Ishoika, S., and Yamakido, M. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155: 3711–3715.
Hiyama, K., Hiyama, E., Ishoika, S., Yamakido, M., Inai, K., Gazdar, A.F., Piatyszek, M.A. and Shay, J.W. 1995. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst. 87: 895–902.
Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M., Shay, J.W., and Matsuura, Y. 1995. Telomerase activity in gastric cancer. Cancer Res. 55: 3258–3262.
Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A.F., Hiyama, K., Piatyszek, M.A., and Shay, J.W. 1996. Telomerase activity in human breast tumors. J. Natl. Cancer Inst. 88: 116–122.
Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L.C., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015.
Piatyszek, M.A., Kim, N.W., Weinrich, S.L., Hiyama, K., Hiyama, E., Wright, W.E., and Shay, J.W. 1995. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci. 17: 1–15.
Dix, D. 1989. The role of aging in cancer incidence: an epidemiological study. J. Geron. Biol. Sci. 44: 10–18.
Peto, R., Roe, F.J.C., Lee, P.N., Levy, L., and Clack, J. 1975. Cancer and ageing in mice and men. Brit. J. Cancer 32: 411–426.
Blackburn, E.H. 1994. Telomeres: No end in sight. Cell 77: 621–623.
Greider, C.W. 1995. Mammalian telomere dynamics: healing fragmentation shortening and stabilization. Curr. Opin. Genet. and Dev. 4: 203–211.
Levy, M.Z., Allsopp, R.C., Futcher, A.B., Greider, C.W., and Harley, C.B. 1992. Telomere end-replication problem and cell aging. J. Mol. Biol. 225: 951–960.
Wright, W.E. and Shay, J.W. 1992. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Geron. 27: 383–389.
Shay, J.W., Pereira-Smith, O., and Wright, W.E. 1991. A role for both Rb and p53 in the regulation of cellular senescence. Exp. Cell Res. 196: 33–39.
Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614–636.
Holt, S.E., Wright, W.E., and Shay, J.W. 1996. Regulation of telomerase activity in immortal cell lines. Molec. Cell. Biol. 16: 2932–2939.
Sharma, H.W., Sokoloski, J.A., Perez, J.R., Maltese, J.Y., Sartorelli, A.C., Stein, C.A., Nichols, G., Khaled, Z., Telang, N.T., and Narayanan, R. 1995. Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92: 12343–12346.
Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W. and Shay, J.W. 1996. Telomerase activity in human germline and embryonic tissues and cells. Devel. Genet. 18: 173–179.
Mantell, L.L. and Greider, C.W. 1994. Telomerase activity in germline and embryonic cells of Xenopus. EMBO J. 13: 3211–3217.
Zhang, W., Piatyszek, M.A., Kobayashi, T., Estey, E., Andreeff, M., Deisseroth, A.B., Wright, W.E., and Shay, J.W. 1996. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin. Cancer Res. 2: 799–803.
Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green, D.K., and Allshire, R.C. 1990. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866–868.
Vaziri, H., Dragowska, W., Allsopp, R.C., Thomas, T.E., Harley, C.B., and Lansdorp, P.M. 1994. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91: 9857–9860.
Taylor, R.S., Ramirez, R.D., Ogoshi, M., Chaffins, M., Piatyszek, M.A., and Shay, J.W. 1996. Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Invest. Dermatol. 106: 759–765.
Broccolli, D., Young, J.W., and de Lange, T. 1995. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92: 9082–9086.
Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S., and Reddel, R.R. 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14: 4240–4248.
Murnane, J.R., Sabatier, L., Marder, B.A., and Morgan, W.F. 1994. Telomere dynamics in an immortal human cell line. EMBO J. 13: 4953–4962.
Lundblad, V. and Szostak, J.W. 1989. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57: 633–643.
Singer, M.S. and Gottschling, D.E. TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266: 404–409 1994.
McEachern, M.J. and Blackburn, E.H. 1995. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376: 403–409.
Steiner, B.R., Hidaka, K., and Futcher, B. 1996. Association of the est1 protein with telomerase activity in yeast. Proc. Natl. Acad. Sci. USA 93: 2817–2821.
Lundblad, V. and Blackburn, E.H. 1993. An alternate pathway for yeast telomere maintenance rescues est1-senescence. Cell 73: 347–360.
Hiyama, E., Yokoyama, T., Hiyama, K., Yamakido, M., Santo, T., Kodama, T., Ichikawa, T., and Matsuura, Y. 1994. Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int. J. Oncol. 6: 13–16.
Greaves, M. 1996. Telomerase activation, stem cells and cancer. Trends Genet. 12: 127–128.
Shay, J.W. and Wright, W.E. 1996. The reactivation of telomerase activity in cancer progression. Trends Genet. 12: 129–131.
Hooper, M.L. 1994. The role of p53 and Rb-1 genes in cancer, development and apoptosis. J. Cell Sci. 18: (suppl.) 13–17.
Hiyama, K., Ishioka, S., Shirotani, Y., Inai, K., Hiyama, E., Murakami, I., Isobe, T., Inamizu, T., and Yamakido, M. 1992. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and pRB. Oncogene 10: 937–944.
Wynford-Thomas, D., Bond, J.A., Wyllie, F.S., and Jones, C.J. 1995. Does telomere shortening drive selection for p53 mutation in human cancer? Molec. Carcino. 12: 119–23.
Feng, J., Funk, W.D., Wang, S.-S., Weinrich, S.L., Avilion, A.A., Chiu, C.-P., Adams, R.R., Chang, E., Allsopp, R.C., Yu, J., Le, S., West, M.D., Harley, C.B., Andrews, W.H., Greider, C.W., and Villeponteau, B. 1995. The RNA component of human telomerase. Science 269: 1236–1241.
Avilion, A.A., Piatyszek, M.A., Gupta, J., Shay, J.W., Bacchetti, S., and Greider, C.W. 1996. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56: 645–650.
Blasco, M.A., Rizen, M., Greider, C.W., and Hanahan, D. 1996. Differential regulation of telomerase activity and telomerase RNA during multi-stage-tumorigenesis. Nature Genet., 12: 200–204.
Wright, W.E., Shay, J.W. and Piatyszek, M.A. 1995. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nuc. Acids Res. 23: 3794–3795.
Shay, J.W. 1995. Aging and cancer: Are telomeres and telomerase the connection?. Mol. Med. Today 1: 378–384.
Shay, J.W., and Wright, W.E. 1996. Telomerase activity in human cancer. Curr. Opin. Oncol. 8: 66–71.
Shay, J.W., Werbin, H., and Wright, W.E. 1996. Telomeres and telomerase in human leukemias. Leukemia. In press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holt, S., Shay, J. & Wright, W. Refining the telomere-telomerase hypothesis of aging and cancer. Nat Biotechnol 14, 836–839 (1996). https://doi.org/10.1038/nbt0796-836
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0796-836
This article is cited by
-
Momordica charantia polysaccharide ameliorates D-galactose-induced aging through the Nrf2/β-Catenin signaling pathway
Metabolic Brain Disease (2023)
-
Mec1ATR is needed for extensive telomere elongation in response to ethanol in yeast
Current Genetics (2018)
-
TPP1 as a versatile player at the ends of chromosomes
Frontiers in Biology (2014)
-
Cdkn1b overexpression in adult mice alters the balance between genome and tissue ageing
Nature Communications (2013)
-
Human Papilloma Virus (HPV) and Host Cellular Interactions
Pathology & Oncology Research (2008)